Platelet-derived growth factor protects neurons against gp120-mediated toxicity

Fuwang Peng, Navneet Dhillon, Shannon Callen, Honghong Yao, Sirosh Bokhari, Xuhui Zhu, Hicham H. Baydoun, Shilpa J. Buch

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The human immunodeficiency virus (HIV)-1 envelope glycoprotein gp120 has been implicated in mediating neuronal apoptosis, a hallmark feature of HIV-associated dementia (HAD). Mitigation of the toxic effects of gp120 could thus be a potential mechanism for reducing HIV toxicity in the brain. In this study the authors hypothesized that neurotrophic factor, such as platelet-derived growth factor (PDGF), could protect the neurons against gp120-mediated apoptosis. SH-SY5Y cells treated with gp120 exhibited increased cell death when measured by lactate dehydrogenase (LDH) and deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assay, with concomitant loss of neurites and increased cell rounding. Pretreatment with PDGF-BB, however, reduced gp120-associated neurotoxicity and rescued the neurite outgrowth. Additionally, gp120-mediated activation of caspase-3 was also significantly reduced in cells pretreated with PDGF-BB. Antiapoptotic effects of PDGF-BB were also confirmed by monitoring levels of anti- and proapoptotic genes, Bcl-xL and Bax, respectively. Furthermore, PDGF-mediated protection against gp120 involved the phosphoinositide (PI) 3-kinase/Akt pathway. Taken together these findings lead us to suggest that PDGF-BB could be considered as a therapeutic agent that can mitigate gp120-mediated neurotoxicity in HAD.

Original languageEnglish (US)
Pages (from-to)62-72
Number of pages11
JournalJournal of neurovirology
Volume14
Issue number1
DOIs
StatePublished - Mar 1 2008

Fingerprint

Platelet-Derived Growth Factor
Neurons
HIV
AIDS Dementia Complex
Apoptosis
1-Phosphatidylinositol 4-Kinase
DNA Nucleotidylexotransferase
Poisons
In Situ Nick-End Labeling
Nerve Growth Factors
Neurites
L-Lactate Dehydrogenase
Caspase 3
Dementia
HIV-1
Glycoproteins
Cell Death
platelet-derived growth factor BB
Brain
Genes

Keywords

  • Gp120
  • HIV dementia
  • Neurons
  • PDGF

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cellular and Molecular Neuroscience
  • Virology

Cite this

Platelet-derived growth factor protects neurons against gp120-mediated toxicity. / Peng, Fuwang; Dhillon, Navneet; Callen, Shannon; Yao, Honghong; Bokhari, Sirosh; Zhu, Xuhui; Baydoun, Hicham H.; Buch, Shilpa J.

In: Journal of neurovirology, Vol. 14, No. 1, 01.03.2008, p. 62-72.

Research output: Contribution to journalArticle

Peng, F, Dhillon, N, Callen, S, Yao, H, Bokhari, S, Zhu, X, Baydoun, HH & Buch, SJ 2008, 'Platelet-derived growth factor protects neurons against gp120-mediated toxicity', Journal of neurovirology, vol. 14, no. 1, pp. 62-72. https://doi.org/10.1080/13550280701809084
Peng, Fuwang ; Dhillon, Navneet ; Callen, Shannon ; Yao, Honghong ; Bokhari, Sirosh ; Zhu, Xuhui ; Baydoun, Hicham H. ; Buch, Shilpa J. / Platelet-derived growth factor protects neurons against gp120-mediated toxicity. In: Journal of neurovirology. 2008 ; Vol. 14, No. 1. pp. 62-72.
@article{9d096b1f9ca24da0a761ad44f570213d,
title = "Platelet-derived growth factor protects neurons against gp120-mediated toxicity",
abstract = "The human immunodeficiency virus (HIV)-1 envelope glycoprotein gp120 has been implicated in mediating neuronal apoptosis, a hallmark feature of HIV-associated dementia (HAD). Mitigation of the toxic effects of gp120 could thus be a potential mechanism for reducing HIV toxicity in the brain. In this study the authors hypothesized that neurotrophic factor, such as platelet-derived growth factor (PDGF), could protect the neurons against gp120-mediated apoptosis. SH-SY5Y cells treated with gp120 exhibited increased cell death when measured by lactate dehydrogenase (LDH) and deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assay, with concomitant loss of neurites and increased cell rounding. Pretreatment with PDGF-BB, however, reduced gp120-associated neurotoxicity and rescued the neurite outgrowth. Additionally, gp120-mediated activation of caspase-3 was also significantly reduced in cells pretreated with PDGF-BB. Antiapoptotic effects of PDGF-BB were also confirmed by monitoring levels of anti- and proapoptotic genes, Bcl-xL and Bax, respectively. Furthermore, PDGF-mediated protection against gp120 involved the phosphoinositide (PI) 3-kinase/Akt pathway. Taken together these findings lead us to suggest that PDGF-BB could be considered as a therapeutic agent that can mitigate gp120-mediated neurotoxicity in HAD.",
keywords = "Gp120, HIV dementia, Neurons, PDGF",
author = "Fuwang Peng and Navneet Dhillon and Shannon Callen and Honghong Yao and Sirosh Bokhari and Xuhui Zhu and Baydoun, {Hicham H.} and Buch, {Shilpa J.}",
year = "2008",
month = "3",
day = "1",
doi = "10.1080/13550280701809084",
language = "English (US)",
volume = "14",
pages = "62--72",
journal = "Journal of NeuroVirology",
issn = "1355-0284",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Platelet-derived growth factor protects neurons against gp120-mediated toxicity

AU - Peng, Fuwang

AU - Dhillon, Navneet

AU - Callen, Shannon

AU - Yao, Honghong

AU - Bokhari, Sirosh

AU - Zhu, Xuhui

AU - Baydoun, Hicham H.

AU - Buch, Shilpa J.

PY - 2008/3/1

Y1 - 2008/3/1

N2 - The human immunodeficiency virus (HIV)-1 envelope glycoprotein gp120 has been implicated in mediating neuronal apoptosis, a hallmark feature of HIV-associated dementia (HAD). Mitigation of the toxic effects of gp120 could thus be a potential mechanism for reducing HIV toxicity in the brain. In this study the authors hypothesized that neurotrophic factor, such as platelet-derived growth factor (PDGF), could protect the neurons against gp120-mediated apoptosis. SH-SY5Y cells treated with gp120 exhibited increased cell death when measured by lactate dehydrogenase (LDH) and deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assay, with concomitant loss of neurites and increased cell rounding. Pretreatment with PDGF-BB, however, reduced gp120-associated neurotoxicity and rescued the neurite outgrowth. Additionally, gp120-mediated activation of caspase-3 was also significantly reduced in cells pretreated with PDGF-BB. Antiapoptotic effects of PDGF-BB were also confirmed by monitoring levels of anti- and proapoptotic genes, Bcl-xL and Bax, respectively. Furthermore, PDGF-mediated protection against gp120 involved the phosphoinositide (PI) 3-kinase/Akt pathway. Taken together these findings lead us to suggest that PDGF-BB could be considered as a therapeutic agent that can mitigate gp120-mediated neurotoxicity in HAD.

AB - The human immunodeficiency virus (HIV)-1 envelope glycoprotein gp120 has been implicated in mediating neuronal apoptosis, a hallmark feature of HIV-associated dementia (HAD). Mitigation of the toxic effects of gp120 could thus be a potential mechanism for reducing HIV toxicity in the brain. In this study the authors hypothesized that neurotrophic factor, such as platelet-derived growth factor (PDGF), could protect the neurons against gp120-mediated apoptosis. SH-SY5Y cells treated with gp120 exhibited increased cell death when measured by lactate dehydrogenase (LDH) and deoxynucleotidyltransferase-mediated dUTP nick end labeling (TUNEL) assay, with concomitant loss of neurites and increased cell rounding. Pretreatment with PDGF-BB, however, reduced gp120-associated neurotoxicity and rescued the neurite outgrowth. Additionally, gp120-mediated activation of caspase-3 was also significantly reduced in cells pretreated with PDGF-BB. Antiapoptotic effects of PDGF-BB were also confirmed by monitoring levels of anti- and proapoptotic genes, Bcl-xL and Bax, respectively. Furthermore, PDGF-mediated protection against gp120 involved the phosphoinositide (PI) 3-kinase/Akt pathway. Taken together these findings lead us to suggest that PDGF-BB could be considered as a therapeutic agent that can mitigate gp120-mediated neurotoxicity in HAD.

KW - Gp120

KW - HIV dementia

KW - Neurons

KW - PDGF

UR - http://www.scopus.com/inward/record.url?scp=39849097691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39849097691&partnerID=8YFLogxK

U2 - 10.1080/13550280701809084

DO - 10.1080/13550280701809084

M3 - Article

C2 - 18300076

AN - SCOPUS:39849097691

VL - 14

SP - 62

EP - 72

JO - Journal of NeuroVirology

JF - Journal of NeuroVirology

SN - 1355-0284

IS - 1

ER -